Accessibility Menu
Albemarle Stock Quote

Albemarle (NYSE: ALB)

$88.40
(-8.4%)
-8.13
Price as of November 4, 2025, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$88.45
Daily Change
(-8.4%) $8.13
Day's Range
$88.01 - $92.50
Previous Close
$88.45
Open
$91.71
Beta
1.58
Volume
4,812,573
Average Volume
3,756,461
Sector
Market Cap
11.4B
Market Cap / Employee
$96.53M
52wk Range
$49.43 - $113.91
Revenue
-
Gross Margin
0.08%
Dividend Yield
1.68%
EPS
-$9.33
CAPs Rating
-
Industry
Chemicals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Albemarle Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
ALB-10.14%-11.07%-2.32%+2,092%
S&P+19.61%+98.99%+14.75%+1,353%

Albemarle Company Info

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following business segments: Lithium, Bromine, Catalysts, and All Other. The Lithium segment develops and manufactures basic lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and value-added lithium specialties and reagents. The Bromine segment consists of bromine and bromine-based businesses including products used in fire safety solutions and other specialty chemicals applications. The Catalysts segment contains two product lines: clean fuel technologies, which are primarily composed of hydro processing catalysts, and heavy oil upgrading that is composed of fluidized catalytic cracking catalysts and additives. The All Other segment includes the FCS business. The company was founded in 1993 and is headquartered in Charlotte, NC.

News & Analysis

The Fool has written over 300 articles on Albemarle.

Financial Health

General

Q2 2025YOY Change
Revenue$1.33B-7.0%
Gross Profit$196.88M1961.2%
Gross Margin14.80%15.5%
Market Cap$7.37B-34.3%
Market Cap / Employee$0.89M0.0%
Employees8.3K-7.8%
Net Income$35.19M119.9%
EBITDA$222.47M521.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$1.81B-1.3%
Accounts Receivable$766.43M-2.4%
Inventory1.6K-8.8%

Liabilities

Q2 2025YOY Change
Long Term Debt$3.27B-9.8%
Short Term Debt$473.58M1399.6%

Ratios

Q2 2025YOY Change
Return On Assets-5.21%-2.5%
Return On Invested Capital6.75%-3.3%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$126.83M-49.7%
Operating Free Cash Flow-$7.20M-102.0%

Valuation

MetricQ4 2023Q1 2024YoY Change
Price to Earnings10.8347.96-
Price to Book1.241.261.100.95-21.65%
Price to Sales1.711.881.661.48-1.89%
Price to Tangible Book Value1.561.651.431.24-18.06%
Enterprise Value to EBITDA-134.25102.0572.3353.07-118.02%
Return on Equity-18.6%-12.2%-10.6%-8.7%81.88%
Total Debt$3.71B$3.65B$3.67B$3.75B2.37%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.